It is well established that decreased muscle contraction and impaired skeletal muscle metabolism in terms of altered insulin signaling and/or mitochondrial dysfunction play a major role in the development of metabolic diseases such as obesity, insulin resistance, and T2D, leading to cardiometabolic complications [141]. This evidence concerns the gene INS and type 2 diabetes mellitus.